FOSDEM 2026 Amid growing interest in digital sovereignty and getting data out of the corporate cloud and into organizations' ownership, the Matrix open communication protocol is thriving. The project ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A St. Louis biotech company has ...

Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.

Department of Chemistry, University of California, Irvine, 1102 Natural Sciences 2, Irvine, California 92697-2025, United States Department of Molecular Biology and Biochemistry, University of ...

Department of Biochemical Engineering, School of Chemical Engineering and Technology, State Key Laboratory of Synthetic Biology, Frontier Science Center for Synthetic Biology, Key Laboratory of ...

SAN DIEGO--(BUSINESS WIRE)--Cofactor Genomics announced the latest validation results for OncoPrism ®, Cofactor’s breakthrough RNA-based diagnostic approach at the RNA Society’s 30th Annual Meeting.

ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics announced today OncoPrism for colorectal, breast, bladder, and kidney cancer. This announcement follows recent Medicare coverage of the OncoPrism ...

An international criminal communications network, known as the Matrix, containing more than 2 million encrypted messages in 33 languages and spanning 40 servers, has been broken apart by a ...

Cofactor AI, a company that helps hospitals appeal claims denials, announced it raised $4 million in a seed funding round led by Drive Capital. Cofactor AI’s platform, Cofactor Denial Suite, combines ...